Previous close | 7.61 |
Open | 7.10 |
Bid | 6.89 x 100 |
Ask | 6.98 x 100 |
Day's range | 6.75 - 7.35 |
52-week range | 4.14 - 9.37 |
Volume | |
Avg. volume | 1,403,801 |
Market cap | 2.599B |
Beta (5Y monthly) | 1.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.02 |
Earnings date | 07 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 8.76 |
Earnings are in focus as multiple companies, such as GoodRx (GDRX) and Roblox (RBLX), reported their latest quarterly results. Data reveals that stock buybacks have reached their highest level since 2018 during this earnings season. Alphabet (GOOG, GOOGL) is reportedly in talks to acquire software developer HubSpot (HUBS). For more expert insight and the latest market action, click here.
GoodRx (GDRX) shares are sliding after the company’s latest earnings report fell below analyst estimates. Yahoo Finance Senior Reporter Anjalee Khemlani joins Catalysts to break down GoodRx's earnings and how the mixed results are weighing on the company's stock valuation. While revenues are up year-over-year, the company missed on earnings per share. GoodRx also saw its general subscriptions decline 6% amid a lawsuit and a decrease in its savings plan with Kroger. However, there have been some increases, especially in the company’s integrated savings program. GoodRx has partnered with major insurers to automatically apply savings to patient prescriptions. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Melanie Riehl
The headline numbers for GoodRx (GDRX) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.